Applied Therapeutics, Inc. Recorded Big Gain

Applied Therapeutics, Inc. (APLT:NASDAQ) rocketted at $1.24, a gain of 121.3%. On Fri, Sep 26, 2025, APLT:NASDAQ hit a New 2-Week High of $1.24. The stock appeared on our News Catalysts scanner on Sun, Sep 07, 2025 at 09:01 PM in the 'BIOTECH' category. From Fri, Sep 12, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days

About Applied Therapeutics, Inc. (APLT:NASDAQ)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.